Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, April to June 2022
Updated 11 July 2024
Applies to England
![](https://assets.publishing.service.gov.uk/media/633ab36c8fa8f541066f73ce/info1.png)
![](https://assets.publishing.service.gov.uk/media/633ab36cd3bf7f6d2a1c1c8b/info2.png)
![](https://assets.publishing.service.gov.uk/media/633ab36c8fa8f541095798f9/info3.png)
P. aeruginosa bacteraemia
April – June 2021 7 out of every 100,000 persons developed a P. aeruginosa bacteraemia.
April - June 2022 7 out of every 100,000 persons developed a P. aeruginosa bacteraemia.
Klebsiella spp. bacteraemia
April - June 2021 18 out of every 100,000 persons developed a Klebsiella spp. bacteraemia.
April – June 2022 19 out of every 100,000 persons developed a Klebsiella spp. bacteraemia.
E. coli bacteraemia
April – June 2021 69 out of every 100,000 persons developed an E. coli bacteraemia.
April - June 2022 68 out of every 100,000 persons developed an E. coli bacteraemia.
MRSA bacteraemia
April - June 2021 1.0 out of every 100,000 persons developed an MRSA bacteraemia.
April – June 2022 1.2 out of every 100,000 persons developed an MRSA bacteraemia.
MSSA bacteraemia
April – June 2021 21 out of every 100,000 persons developed an MSSA bacteraemia.
April – June 2022 23 out of every 100,000 persons developed an MSSA bacteraemia.
C. difficile infection
April – June 2021 25 out of every 100,000 persons developed a C. difficile infection.
April - June 2022 27 out of every 100,000 persons developed a C. difficile